申请人:Hennequin Francois Andre Laurent
公开号:US20050043336A1
公开(公告)日:2005-02-24
The invention concerns quinazoline derivatives of Formula (I); wherein each of Q
1
, Q
2
, Z, R
1
, R
2
, R
3
, and m have any of the meanings defined in the description; processes for their preparation, pharmaceutical compositions containing them and their use in the manufacture of a medicament for use in the prevention or treatment of tumours which are sensitive to inhibition of erbB receptor tyrosin kinases.
该发明涉及公式(I)的喹唑啉衍生物;其中Q1,Q2,Z,R1,R2,R3和m的每个定义在说明中具有任何意义;它们的制备过程,包含它们的制药组合物以及它们在制造对erbB受体酪氨酸激酶抑制敏感的肿瘤的预防或治疗药物中的使用。